Myricanone

CAS : 32492-74-3

Ref. 3D-HBA49274

Informations sur le produit

• Nom: Myricanone
• Synonymes: 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.1^2,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, Tricyclo[12.3.1.1^2,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-, Tricyclo[12.3.1.1~2,6~]Nonadeca-1(18),2,4,6(19),14,16-Hexaen-9-One, 3,15-Dihydroxy-16,17-Dimethoxy-, 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-

Description

Myricanone is a synthetic curcumin analog that is used to treat bowel disease, skin cancer, and other conditions. It has been shown to inhibit protein target nitro (PTN), a key enzyme in the synthesis of proteins involved in inflammation and cancer. Myricanone also inhibits the growth of cancer cells by inhibiting their ability to divide and proliferate. Myricanone has been found to have anti-inflammatory effects, which may be due to its inhibition of cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2). Myricanone has also been shown to have sodium-dependent glucose cotransporter 1 (SGLT1) activity. The compound causes mitochondrial membrane depolarization by inhibiting complex I of the electron transport chain.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 356.4 g/mol
• Formule: C₂₁H₂₄O₅
• Degré de pureté: Min. 95%